Liabilities of Edesa Biotech, Inc. from 31 Aug 2013 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Edesa Biotech, Inc. quarterly Liabilities in USD history and change rate from 31 Aug 2013 to 30 Sep 2024.
  • Edesa Biotech, Inc. Liabilities for the quarter ending 30 Sep 2024 was $1,832,827, a 0.48% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $1,832,827 -$8,810 -0.48% 30 Sep 2024 10-K 13 Dec 2024 2024 FY
Q2 2024 $2,360,627 +$791,586 +50% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q3
Q1 2024 $2,150,723 +$477,175 +29% 31 Mar 2024 10-Q 10 May 2024 2024 Q2
Q4 2023 $1,986,912 +$585,606 +42% 31 Dec 2023 10-Q 09 Feb 2024 2024 Q1
Q3 2023 $1,841,637 -$342,802 -16% 30 Sep 2023 10-K 13 Dec 2024 2024 FY
Q2 2023 $1,569,041 -$4,134,824 -72% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q3
Q1 2023 $1,673,548 -$1,709,662 -51% 31 Mar 2023 10-Q 11 May 2023 2023 Q2
Q4 2022 $1,401,306 -$392,805 -22% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q1
Q3 2022 $2,184,439 +$658,075 +43% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q2 2022 $5,703,865 +$4,630,277 +431% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q3
Q1 2022 $3,383,210 -$1,345,696 -28% 31 Mar 2022 10-Q 13 May 2022 2022 Q2
Q4 2021 $1,794,111 +$760,779 +74% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q1
Q3 2021 $1,526,364 -$127,881 -7.7% 30 Sep 2021 10-K 16 Dec 2022 2022 FY
Q2 2021 $1,073,588 -$48,977 -4.4% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q3
Q1 2021 $4,728,906 +$4,027,225 +574% 31 Mar 2021 10-Q 14 May 2021 2021 Q2
Q4 2020 $1,033,332 +$177,656 +21% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 $1,654,245 +$1,192,611 +258% 30 Sep 2020 10-K 28 Dec 2021 2021 FY
Q2 2020 $1,122,565 30 Jun 2020 10-Q 12 Aug 2020 2020 Q3
Q1 2020 $701,681 31 Mar 2020 10-Q 15 May 2020 2020 Q2
Q4 2019 $855,676 31 Dec 2019 10-Q 13 Feb 2020 2020 Q1
Q3 2019 $461,634 30 Sep 2019 10-K 07 Dec 2020 2020 FY
Q3 2015 $2,380,648 -$1,982,332 -45% 30 Sep 2015 10-K 14 Dec 2015 2015 FY
Q2 2015 $1,780,438 30 Jun 2015 10-Q 10 Aug 2015 2015 Q3
Q1 2015 $2,903,875 31 Mar 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 $4,188,951 31 Dec 2014 10-Q 09 Feb 2015 2015 Q1
Q3 2014 $4,362,980 -$6,346,377 -59% 30 Sep 2014 10-K 14 Dec 2015 2015 FY
Q3 2013 $10,709,357 31 Aug 2013 10-K 21 Nov 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.